Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
JCO Oncology Practice
|
September 21, 2020
Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast-Count Acute Myeloid Leukemia
Lee Mozessohn, Matthew C Cheung, Nicole Mittmann, et al.
Journal of the National Cancer Institute
|
April 20, 2017
Response
Lee Mozessohn, Craig C Earle, David Spaner, et al.
American Journal of Hematology
|
March 17, 2026
Interfollicular Plasmacytosis and Hyperplastic Germinal Centers in Idiopathic Multicentric Castleman Disease, Idiopathic Plasmacytic Lymphadenopathy Subtype
Stephanie Quon, Clarissa Skorupski, Christophe Langlois, et al.
British Journal of Haematology
|
April 19, 2020
Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects
Liam Smyth, Danielle N Blunt, Evgenia Gatov, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2021
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry
Danielle N Blunt, Liam Smyth, Chenthila Nagamuthu, et al.
British Journal of Cancer
|
July 8, 2023
Fracture risk among patients with cancer compared to individuals without cancer: a population-based study
Inna Y Gong, Kelvin K W Chan, Lorraine L Lipscombe, et al.
The Canadian Journal of Hospital Pharmacy
|
March 18, 2014
Management of severe dabigatran-related hemorrhage: case report, considerations for management, and recommendations
Ian Plener, Sharon Sadry, Lee Mozessohn, et al.
Leukemia & Lymphoma
|
January 24, 2024
The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study
Sumedha Arya, Lee Mozessohn, Inna Gong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 17, 2022
Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study
Abi Vijenthira, Lee Mozessohn, Chenthila Nagamuthu, et al.
British Journal of Haematology
|
May 17, 2018
Azacitidine in the 'real-world': an evaluation of 1101 higher-risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada
Lee Mozessohn, Matthew C Cheung, Saber Fallahpour, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
JCO Oncology Practice
|
September 21, 2020
Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast-Count Acute Myeloid Leukemia
Lee Mozessohn, Matthew C Cheung, Nicole Mittmann, et al.
Journal of the National Cancer Institute
|
April 20, 2017
Response
Lee Mozessohn, Craig C Earle, David Spaner, et al.
American Journal of Hematology
|
March 17, 2026
Interfollicular Plasmacytosis and Hyperplastic Germinal Centers in Idiopathic Multicentric Castleman Disease, Idiopathic Plasmacytic Lymphadenopathy Subtype
Stephanie Quon, Clarissa Skorupski, Christophe Langlois, et al.
British Journal of Haematology
|
April 19, 2020
Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects
Liam Smyth, Danielle N Blunt, Evgenia Gatov, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2021
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry
Danielle N Blunt, Liam Smyth, Chenthila Nagamuthu, et al.
British Journal of Cancer
|
July 8, 2023
Fracture risk among patients with cancer compared to individuals without cancer: a population-based study
Inna Y Gong, Kelvin K W Chan, Lorraine L Lipscombe, et al.
The Canadian Journal of Hospital Pharmacy
|
March 18, 2014
Management of severe dabigatran-related hemorrhage: case report, considerations for management, and recommendations
Ian Plener, Sharon Sadry, Lee Mozessohn, et al.
Leukemia & Lymphoma
|
January 24, 2024
The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study
Sumedha Arya, Lee Mozessohn, Inna Gong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 17, 2022
Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study
Abi Vijenthira, Lee Mozessohn, Chenthila Nagamuthu, et al.
British Journal of Haematology
|
May 17, 2018
Azacitidine in the 'real-world': an evaluation of 1101 higher-risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada
Lee Mozessohn, Matthew C Cheung, Saber Fallahpour, et al.
Page
of 5